FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2747388177> ?p ?o ?g. }

• W2747388177 endingPage "4824" @default.
• W2747388177 startingPage "4817" @default.
• W2747388177 abstract "Since the 1990s, self-controlled designs including self-controlled case series (SCCS) studies have been occasionally used in post-marketing evaluation of drug or vaccine safety. An SCCS study was tentatively applied to evaluate the relationship between oseltamivir use and abnormal behavior Type A (serious abnormal behavior potentially leading to an accident or harm to another person) in influenza patients.From the original prospective cohort study with approximately 10,000 Japanese children and adolescents with influenza (aged <18years), 28 subjects (mean age: 7.3years) who developed abnormal behavior Type A after the first visit to the collaborating hospitals/clinics were analyzed. We hypothesized four combination patterns of the effect period (i.e., the period that effect of oseltamivir on occurrence of abnormal behavior Type A is likely) and the control period. Mantel-Haenszel rate ratio (M-H RR) and its 95% confidence interval (CI) were calculated as the relative risk estimate.Among 28 subjects in the SCCS study, 24 subjects (86%) were administered oseltamivir and 4 subjects (14%) were not. Abnormal behavior Type A was more likely to occur in the effect period than the control period in every pattern (M-H RR: 1.90-29.1). We observed the highest estimate when the effect period was set between the initial intake of oseltamivir and Tmax (M-H RR: 29.1, 95% CI: 4.21-201).Abnormal behavior Type A was more likely to develop up to approximately 30 times during the period between the initial intake of oseltamivir and Tmax. However, this period overlapped with the early period of influenza where high fever was observed. Since useful approaches to control the influence of the natural disease course of influenza were not available in this study, we could not deny the possibility that abnormal behavior was induced by influenza itself. The SCCS study was not an optimal method to evaluate the relationship between oseltamivir use and abnormal behavior." @default.
• W2747388177 created "2017-08-31" @default.
• W2747388177 creator A5001090879 @default.
• W2747388177 creator A5019397425 @default.
• W2747388177 creator A5020676620 @default.
• W2747388177 creator A5023047393 @default.
• W2747388177 creator A5027839812 @default.
• W2747388177 creator A5028962718 @default.
• W2747388177 creator A5029309344 @default.
• W2747388177 creator A5030545387 @default.
• W2747388177 creator A5034716431 @default.
• W2747388177 creator A5042543331 @default.
• W2747388177 creator A5043626530 @default.
• W2747388177 creator A5065120657 @default.
• W2747388177 creator A5067319030 @default.
• W2747388177 creator A5084578086 @default.
• W2747388177 creator A5085519388 @default.
• W2747388177 creator A5086728803 @default.
• W2747388177 creator A5086987725 @default.
• W2747388177 date "2017-08-01" @default.
• W2747388177 modified "2023-10-18" @default.
• W2747388177 title "Oseltamivir use and severe abnormal behavior in Japanese children and adolescents with influenza: Is a self-controlled case series study applicable?" @default.
• W2747388177 cites W1561057973 @default.
• W2747388177 cites W1965434221 @default.
• W2747388177 cites W1971411608 @default.
• W2747388177 cites W1974675654 @default.
• W2747388177 cites W1978487827 @default.
• W2747388177 cites W1980915464 @default.
• W2747388177 cites W1988394758 @default.
• W2747388177 cites W1989727346 @default.
• W2747388177 cites W2001770851 @default.
• W2747388177 cites W2007006833 @default.
• W2747388177 cites W2068566053 @default.
• W2747388177 cites W2095718021 @default.
• W2747388177 cites W2129905200 @default.
• W2747388177 cites W2136527705 @default.
• W2747388177 cites W2148383246 @default.
• W2747388177 cites W2166293995 @default.
• W2747388177 cites W2312663826 @default.
• W2747388177 cites W796299009 @default.
• W2747388177 doi "https://doi.org/10.1016/j.vaccine.2017.07.007" @default.
• W2747388177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28818475" @default.
• W2747388177 hasPublicationYear "2017" @default.
• W2747388177 type Work @default.
• W2747388177 sameAs 2747388177 @default.
• W2747388177 citedByCount "9" @default.
• W2747388177 countsByYear W27473881772018 @default.
• W2747388177 countsByYear W27473881772019 @default.
• W2747388177 countsByYear W27473881772020 @default.
• W2747388177 countsByYear W27473881772021 @default.
• W2747388177 countsByYear W27473881772022 @default.
• W2747388177 crossrefType "journal-article" @default.
• W2747388177 hasAuthorship W2747388177A5001090879 @default.
• W2747388177 hasAuthorship W2747388177A5019397425 @default.
• W2747388177 hasAuthorship W2747388177A5020676620 @default.
• W2747388177 hasAuthorship W2747388177A5023047393 @default.
• W2747388177 hasAuthorship W2747388177A5027839812 @default.
• W2747388177 hasAuthorship W2747388177A5028962718 @default.
• W2747388177 hasAuthorship W2747388177A5029309344 @default.
• W2747388177 hasAuthorship W2747388177A5030545387 @default.
• W2747388177 hasAuthorship W2747388177A5034716431 @default.
• W2747388177 hasAuthorship W2747388177A5042543331 @default.
• W2747388177 hasAuthorship W2747388177A5043626530 @default.
• W2747388177 hasAuthorship W2747388177A5065120657 @default.
• W2747388177 hasAuthorship W2747388177A5067319030 @default.
• W2747388177 hasAuthorship W2747388177A5084578086 @default.
• W2747388177 hasAuthorship W2747388177A5085519388 @default.
• W2747388177 hasAuthorship W2747388177A5086728803 @default.
• W2747388177 hasAuthorship W2747388177A5086987725 @default.
• W2747388177 hasConcept C126322002 @default.
• W2747388177 hasConcept C144024400 @default.
• W2747388177 hasConcept C149923435 @default.
• W2747388177 hasConcept C187212893 @default.
• W2747388177 hasConcept C188816634 @default.
• W2747388177 hasConcept C201903717 @default.
• W2747388177 hasConcept C2779134260 @default.
• W2747388177 hasConcept C2780374985 @default.
• W2747388177 hasConcept C3008058167 @default.
• W2747388177 hasConcept C44249647 @default.
• W2747388177 hasConcept C524204448 @default.
• W2747388177 hasConcept C71924100 @default.
• W2747388177 hasConcept C72563966 @default.
• W2747388177 hasConcept C82789193 @default.
• W2747388177 hasConceptScore W2747388177C126322002 @default.
• W2747388177 hasConceptScore W2747388177C144024400 @default.
• W2747388177 hasConceptScore W2747388177C149923435 @default.
• W2747388177 hasConceptScore W2747388177C187212893 @default.
• W2747388177 hasConceptScore W2747388177C188816634 @default.
• W2747388177 hasConceptScore W2747388177C201903717 @default.
• W2747388177 hasConceptScore W2747388177C2779134260 @default.
• W2747388177 hasConceptScore W2747388177C2780374985 @default.
• W2747388177 hasConceptScore W2747388177C3008058167 @default.
• W2747388177 hasConceptScore W2747388177C44249647 @default.
• W2747388177 hasConceptScore W2747388177C524204448 @default.
• W2747388177 hasConceptScore W2747388177C71924100 @default.
• W2747388177 hasConceptScore W2747388177C72563966 @default.
• W2747388177 hasConceptScore W2747388177C82789193 @default.
• W2747388177 hasIssue "36" @default.

• next